Literature DB >> 12458247

Drug points: Dysgeusia and burning mouth syndrome by eprosartan.

Xavier Castells1, Isidre Rodoreda, Consuelo Pedrós, Gloria Cereza, Joan-Ramon Laporte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12458247      PMCID： PMC136926          DOI： 10.1136/bmj.325.7375.1277

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Dysgeusia by Losartan in a Patient Intolerant of Captopril.

Authors: 
Journal:  MedGenMed       Date:  1999-11-04

2.  Reversible dysgeusia attributed to losartan.

Authors:  M Heeringa; E P van Puijenbroek
Journal:  Ann Intern Med       Date:  1998-07-01       Impact factor: 25.391

3.  Reversible ageusia associated with losartan.

Authors:  R G Schlienger; M Saxer; W E Haefeli
Journal:  Lancet       Date:  1996-02-17       Impact factor: 79.321

Review 4.  Comparative safety and tolerability of angiotensin II receptor antagonists.

Authors:  L Mazzolai; M Burnier
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

Review 5.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606
  5 in total
  2 in total

Review 1.  Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review.

Authors:  Xiaoru Che; Yuandong Li; Yuanjian Fang; Cesar Reis; Huan Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

2.  Is Dysguesia Going to be a Rare or a Common Side-effect of Amlodipine?

Authors:  T Pugazhenthan; H Singh; P Kumar; B Hariharan
Journal:  Ann Med Health Sci Res       Date:  2014-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.